LIFE Insura CORP OF India
F&O₹410.00▼ -1.50 (-0.36%)
LICI·NSE·Insurance
Market Cap
525291.06 Cr
PE Ratio
9.03
Volume
67,95,253
Day High - Low
416.25 - 409.75
52W High-Low
468.48 - 360.75
₹410.00▼ -1.50 (-0.36%)
Market Cap525291.06 Cr
PE Ratio9.03
Volume67,95,253
Day High - Low416.25 - 409.75
52W High-Low468.48 - 360.75
DocStoX Intelligence: Life Insura Corp Of India (LICI)
DocStoX rates LICI as “avoid”, scoring 2.3/10 with 74% confidence.
Life Insura Corp Of India (LICI) is a large-cap Insurance company valued at ₹5.25 lakh crore operating in Life Insurance on the NSE and BSE.
- What changed?
- Life Insura Corp Of India last traded at ₹410, modestly down 0.36% on the day.
- Recent developments
- On 2026-08-06, the company reported earnings results for the first quarter ended June 30, 2026. On 2026-08-04, the President of India announced an intention to exercise an over-subscription option for shares. On 2026-06-29, the company's actual results and estimates were released.
- Is the business improving?
- The company's business is improving, with annual revenue rising 9.9% and annual net profit growing 18.9%. The latest quarter saw revenue increase 6.8% compared to the same quarter a year earlier, while net profit rose 24.0%, outpacing revenue growth. The net profit margin expanded 0.4 percentage points to 5.9%, and return on equity remained strong at 37.8%.
- Is it expensive?
- The stock trades at 9.0 times earnings, 3.09 times book value. It yields 2.4%.
- What could go wrong?
- The stock is 12.3% below its 52-week high. The company's market share in new business premium is above 66.2%, but this is a static figure. The promoter holding remains at 96.50%, with no recent changes reported.
- DocStoX conclusion
- DocStoX rates LICI as “avoid”, scoring 2.3/10 with 74% confidence.
Analysis written by DocStoX's model on 2026-09-08 from company filings and market data · verdict updated 2026-09-08. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
7.0/10
Strong
Fair Value
Sign in to see
ROE
37.80%
Strong
P/E
9.03x
Cheap
Debt / Equity
0.00
Low
Industry
Insurance
Life Insurance
Overall View
Strong
Price performance
NIFTY 500NIFTY MIDCAP 150
Day₹409.75
₹416.25
52W₹360.75
₹468.48
DocStoX take
Supported by valuation (9.0) and risk (7.9), but weakest on momentum (4.4).
DocStoX score
Low confidence7.0
/10
Strong
Quality
Solid
ROE 37.8%
Valuation
Cheap
P/E 9.0×
Growth
Steady
Revenue +7.2% 5Y CAGR
Risk
Low risk
D/E 0.00 (lender)
Momentum
Soft
46% of 52-week range
At a glance
Market Cap
₹5.25L Cr
52W High / Low
₹468 / ₹361
Dividend Yield
2.40%
Promoter Holding
96.50%
EPS (TTM)
₹45.42
Book Value
₹140.36
Key highlights
- Profit compounding 81% a year
- Strong returns on equity (38%)
- Capital works hard — ROCE 35%
4 Positives0 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Insurance stocks · Life Insurance
Explore LIFE INSURA CORP OF INDIA’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
LIFE INSURA CORP OF INDIA peers in Insurance
Other Insurance stocks on the NSE & BSE. See the full Insurance sector list.
Related tools & concepts
Value LIFE INSURA CORP OF INDIA with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing

